Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

APOGEE ENTERPRISES, INC. Director's Dealing 2020

Nov 12, 2020

32272_dirs_2020-11-12_1400136e-ed23-4330-a56b-4bee2e680e75.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: APOGEE ENTERPRISES, INC. (APOG)
CIK: 0000006845
Period of Report: 2020-11-09

Reporting Person: Puishys Joseph F. (Director, Chief Executive Officer & Pres)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-09 Common Stock M 41458 $8.34 Acquired 196918 Direct
2020-11-09 Common Stock S 41458 $25.9944 Disposed 155460 Direct
2020-11-10 Common Stock M 58883 $8.34 Acquired 214343 Direct
2020-11-10 Common Stock S 58883 $25.5583 Disposed 155460 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-09 Option (Right to Buy) $8.34 M 41458 Disposed 2021-08-22 Common Stock (41458) Direct
2020-11-10 Option (Right to Buy) $8.34 M 58883 Disposed 2021-08-22 Common Stock (58883) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 127175 Indirect

Footnotes

F1: Includes restricted stock awards under the 2009 Stock Incentive Plan and 2019 Stock Incentive Plan.

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2020 which was reported on a Form 8-K filed September 25, 2020.

F3: The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $25.21 to $26.90. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.

F4: The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $25.01 to $25.81. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.

F5: Currently 100% exercisable.